Japan Bioindustry Association

What Japan Bioindustry Association does

Japan Bioindustry Association (JBA, 一般財団法人バイオインダストリー協会) is a Tokyo-headquartered general incorporated foundation founded in 1987 (reorganized in 1989 from the Alcohol Research Association) that serves as Japan's primary industry association for bioscience and biotechnology. The organization operates a membership-based platform connecting 549 corporate, academic, and government member organizations — including major pharmaceutical firms (Astellas, Takeda, Chugai), food companies (Ajinomoto), leading universities (Tokyo, Kyoto, Osaka), national research institutes (AIST), and regional governments — across four tiers: special, general, venture, and public members.

JBA's core products and services comprise an integrated ecosystem: the BioJapan partnering event (Japan's largest biotech partnering exhibition); the B&I (Bioscience and Industry) journal; 11–12 specialized study groups covering fermentation, drug modalities, bioengineering, functional foods, plant biotech, healthcare, and related verticals; the BioLeaders Training program (since 2009, with 500+ alumni) for early-career researchers; the Bio Mono Forum (established 2024) focused on bio-manufacturing and bioeconomy; a member-exclusive seminar video distribution service with up to one-year archive access; a comprehensive member portal; and the annual Bioindustry Award (Grand Prize and Encouragement Award) program. Technology is platform-based rather than proprietary — JBA does not develop its own biotech IP, but operates as the convening, knowledge-exchange, and policy-advocacy layer across the Japanese bioindustry.

The revenue model is subscription-recurring through three primary streams: annual corporate and individual membership fees, paid event registration (seminars, the Annual Forum at 16,000–23,000 yen, and BioFuture 2026 in NYC at $795–$1,150 with member discounts), and publication revenue from B&I journal subscriptions. Go-to-market is community-led and event-driven, with the association distributing services through its member portal, YouTube-based Channel JBA, email newsletters, and in-person conferences. Geographic footprint is primarily Japan, with expanding international linkages through the 2025 QUT (Australia) MOU and partnerships with U.S. and APAC biotech events.

Name

Japan Bioindustry Association

Legal name

Japan Bioindustry Association

Website

https://jba.or.jp

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

11–50 employees

Short description

Japan Bioindustry Association is a Tokyo-based non-profit industry association that convenes 549 pharmaceutical, biotech, academic, and government members across Japan to advance bioscience through events, publications, training, and policy advocacy.

Ownership category

akta.pro rank

Product category

Biotechnology Industry Association

NAICS

Business Associations (813910), Professional Organizations (813920)

SIC

Services-Membership Organizations (8600), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors) (EUAAAIAJ)

akta.pro secondary industry

Food Safety, Quality Standards & Regulatory Capacity Building (BPADAJAJ)

Keywords

• Bioindustry association
• Biotechnology networking
• Life sciences events
• Biomanufacturing research
• Bioeconomy policy

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Fees: Annual membership fees from corporate members (special members, general members, venture members, public members) and individual members (academia, general).
2. Event Registration Fees: Paid seminars, forums, and conferences including the Medical Industry Growth Strategy Seminar Annual Forum, BioFuture 2026 partnership events, and other specialized seminars.
3. Publication Revenue: Revenue from the B&I journal (BioScience and Industry) and other publications, with some content available as member-only PDFs.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Japan Bioindustry Association (JBA) is a general incorporated foundation that operates as Japan's primary bioindustry membership association. It delivers services through annual partnering events (BioJapan, BioFuture), the institutional journal Bioscience and Industry (B&I), 12 specialized study groups covering fermentation, drug modalities, functional foods and other biotech domains, the BioLeaders professional training program, seminar video distribution, and policy advocacy for the bioindustry sector.

Product overview

Japan Bioindustry Association (JBA) operates as a membership-based association providing interconnected services including an institutional journal (B&I), annual events (BioJapan, BioFuture), 11 specialized study groups covering fermentation, healthcare, drug modalities and other biotech domains, professional training programs (Bio Leaders Training), video-based seminar distribution, and a member portal for accessing all services. The portfolio functions as an integrated ecosystem for knowledge sharing, business partnering, and professional development in Japan's bioindustry sector.

Differentiator

Problem solved

Functional benefit

Brands

• BioJapan: Major biotechnology partnering event organized by JBA
• Channel JBA
• Bioscience and Industry (B&I)

Products and services

• BioJapan
• Bioscience and Industry (B&I) Journal
• BioLeaders Training (バイオリーダーズ研修)
• Study Groups (Kenkyūkai)
• Bio Mono Forum (バイオモノづくりフォーラム)
• Seminar Video Distribution Service (Channel JBA)
• Bioindustry Awards Program
• JBA Corporate Membership

Quantifiable outcome

• 500+ professionals trained through BioLeaders program since 2009
• +1 more outcomes

Named customers11 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Queensland University of Technology (QUT)coreStrategic or Co-development Partner · 20 October 2025MOU signed to enhance collaboration in biomanufacturing sectors and promote innovation between Japan and Australia. Agreement aims to advance bioindustries, support sustainable development, and foster international knowledge exchange, leveraging Australia's bioeconomy potential.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• CropLife International: Global federation representing plant science companies. Overlaps with JBA's plant biotechnology and bioengineering study groups, but focused on agro-biotech rather than the broader bioindustry scope.
• PhRMA: US pharmaceutical research and manufacturers association. While broader (pharma-focused rather than full bioindustry), PhRMA overlaps with JBA's largest special members (Takeda, Astellas, Chugai) and competes for the same executive-policy engagement.

Direct peers

• Biotechnology Innovation Organization (BIO): The largest US-based biotechnology trade association, serving as the global standard for industry advocacy, partnering events (BIO Convention), and policy lobbying. Directly comparable to JBA as the principal national bioindustry association, with greater international scope.
• KoreaBIO: Korea's biotechnology industry association focused on promoting Korean bioindustry internationally, including BIO Korea and BIOPlus events. Directly comparable as an Asia-Pacific peer serving overlapping pharma/biotech/academia stakeholders.
• AusBiotech: Australia's peak biotechnology industry association organizing industry events, policy advocacy, and member services. Directly comparable given JBA's recent QUT MOU and BioFuture partnerships in the Australia/US corridor.
• EuropaBio: European bioindustries association representing biotechnology across healthcare, industrial, and agricultural applications. Directly comparable as a regional industry association convening companies, researchers, and policymakers.

Others

• Bioprocessing Summit (Informa): Major commercial conference organizer producing bioprocessing-focused events. Adjacent to JBA's Bio Mono Forum and BioJapan, operating in the same biomanufacturing knowledge-sharing space as a for-profit counterpart.

Emerging players

• Council of Industrial Biotechnology (CIB): Specialized council within BIO focused on industrial biotechnology, including biomanufacturing and fermentation. Overlaps with JBA's Bio Mono Forum and biomanufacturing working groups.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/share
• YouTubeyoutube.com/channel/UCiR4DkLM1fbPF1YDNkB3iyA
• Facebookfacebook.com/sharer/sharer.php

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Japan Bioindustry Association